A. Hamosh, A. Scott, J. Amberger, C. Bocchini, and V. Mckusick, Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders, Nucleic Acids Research, vol.33, issue.Database issue, pp.514-517, 2005.
DOI : 10.1093/nar/gki033

J. Casanova and L. Abel, : The Human Model, Annual Review of Immunology, vol.20, issue.1, pp.581-620, 2002.
DOI : 10.1146/annurev.immunol.20.081501.125851

O. Filipe-santos, J. Bustamante, A. Chapgier, G. Vogt, and L. De-beaucoudrey, Inborn errors of IL-12/23- and IFN-??-mediated immunity: molecular, cellular, and clinical features, Seminars in Immunology, vol.18, issue.6, pp.347-361, 2006.
DOI : 10.1016/j.smim.2006.07.010

E. Jouanguy, F. Altare, S. Lamhamedi, P. Revy, and J. Emile, Interferon-?? ???Receptor Deficiency in an Infant with Fatal Bacille Calmette???Gu??rin Infection, New England Journal of Medicine, vol.335, issue.26, pp.1956-1961, 1996.
DOI : 10.1056/NEJM199612263352604

M. Newport, C. Huxley, S. Huston, C. Hawrylowicz, and B. Oostra, A Mutation in the Interferon-?? ???Receptor Gene and Susceptibility to Mycobacterial Infection, New England Journal of Medicine, vol.335, issue.26, pp.1941-1949, 1996.
DOI : 10.1056/NEJM199612263352602

E. Jouanguy, S. Dupuis, A. Pallier, R. Doffinger, and M. Fondaneche, In a novel form of IFN-?? receptor 1 deficiency, cell surface receptors fail to bind IFN-??, Journal of Clinical Investigation, vol.105, issue.10, pp.1429-1436, 2000.
DOI : 10.1172/JCI9166

S. Dorman, C. Picard, D. Lammas, K. Heyne, and J. Van-dissel, Clinical features of dominant and recessive interferon ?? receptor 1 deficiencies, The Lancet, vol.364, issue.9451, pp.2113-2121, 2004.
DOI : 10.1016/S0140-6736(04)17552-1

A. Alcais, C. Fieschi, L. Abel, and J. Casanova, Tuberculosis in children and adults, The Journal of Experimental Medicine, vol.54, issue.12, pp.1617-1621, 2005.
DOI : 10.1086/338625

C. Maclennan, C. Fieschi, D. Lammas, C. Picard, and S. Dorman, Interleukin (IL)???12 and IL???23 Are Key Cytokines for Immunity against Salmonella in Humans, The Journal of Infectious Diseases, vol.190, issue.10, pp.1755-1757, 2004.
DOI : 10.1086/425021

J. Roesler, B. Kofink, J. Wendisch, S. Heyden, and D. Paul, Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-??-receptor (IFN??R1) deficiency Mutational analysis and evaluation of therapeutic options, Experimental Hematology, vol.27, issue.9, pp.1368-1374, 1999.
DOI : 10.1016/S0301-472X(99)00077-6

J. Emile, N. Patey, F. Altare, S. Lamhamedi, and E. Jouanguy, CORRELATION OF GRANULOMA STRUCTURE WITH CLINICAL OUTCOME DEFINES TWO TYPES OF IDIOPATHIC DISSEMINATED BCG INFECTION, The Journal of Pathology, vol.345, issue.1, pp.25-30, 1997.
DOI : 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z

U. Reuter, J. Roesler, C. Thiede, A. Schulz, and C. Classen, Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation, Blood, vol.100, issue.12, pp.4234-4235, 2002.
DOI : 10.1182/blood-2002-02-0433

J. Roesler, M. Horwitz, C. Picard, P. Bordigoni, and G. Davies, Hematopoietic stem cell transplantation for complete IFN-?? receptor 1 deficiency: A multi-institutional survey, The Journal of Pediatrics, vol.145, issue.6, pp.806-812, 2004.
DOI : 10.1016/j.jpeds.2004.08.021

M. Horwitz, G. Uzel, G. Linton, J. Miller, and M. Brown, Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-?? receptor-1 deficiency, Blood, vol.102, issue.7, pp.2692-2694, 2003.
DOI : 10.1182/blood-2003-04-1268

C. Chantrain, A. Bruwier, B. Brichard, V. Largent, and A. Chapgier, Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-?? receptor 1 deficiency, Bone Marrow Transplantation, vol.139, issue.1, pp.75-76, 2006.
DOI : 10.1038/sj.bmt.1705399

C. Antoine, S. Muller, A. Cant, M. Cavazzana-calvo, and P. Veys, Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968???99, The Lancet, vol.361, issue.9357, pp.553-560, 2003.
DOI : 10.1016/S0140-6736(03)12513-5

S. Huang, W. Hendriks, A. Althage, S. Hemmi, and H. Bluethmann, Immune response in mice that lack the interferon-gamma receptor, Science, vol.259, issue.5102, pp.1742-1745, 1993.
DOI : 10.1126/science.8456301

D. Dalton, S. Pitts-meek, S. Keshav, I. Figari, and A. Bradley, Multiple defects of immune cell function in mice with disrupted interferon-gamma genes, Science, vol.259, issue.5102, pp.1739-1742, 1993.
DOI : 10.1126/science.8456300

K. Swihart, U. Fruth, N. Messmer, K. Hug, and R. Behin, Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response, Journal of Experimental Medicine, vol.181, issue.3, pp.961-971, 1995.
DOI : 10.1084/jem.181.3.961

Y. Zhao and A. Tarkowski, Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis, J Immunol, vol.155, pp.5736-5742, 1995.

P. Mastroeni, C. S. Khan, S. Harrison, J. Hormaeche, and C. , Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium, Infect Immun, vol.67, pp.478-483, 1999.

A. Rijneveld, F. Lauw, M. Schultz, S. Florquin, T. Velde et al., The Role of Interferon????? in Murine Pneumococcal Pneumonia, The Journal of Infectious Diseases, vol.185, issue.1, pp.91-97, 2002.
DOI : 10.1086/338122

E. Cantin, B. Tanamachi, and H. Openshaw, Role for gamma interferon in control of herpes simplex virus type 1 reactivation, J Virol, vol.73, pp.3418-3423, 1999.

J. Flynn, J. Chan, K. Triebold, D. Dalton, and T. Stewart, An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection, Journal of Experimental Medicine, vol.178, issue.6, pp.2249-2254, 1993.
DOI : 10.1084/jem.178.6.2249

I. Garcia, Y. Miyazaki, G. Marchal, W. Lesslauer, and P. Vassalli, High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: Synergistic action of TNF and IFN-?? in the differentiation of protective granulomas, European Journal of Immunology, vol.99, issue.12, pp.3182-3190, 1997.
DOI : 10.1002/eji.1830271215

T. Doherty and A. Sher, Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection, J Immunol, vol.158, pp.4822-4831, 1997.

R. Kamijo, J. Le, D. Shapiro, E. Havell, and S. Huang, Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide, Journal of Experimental Medicine, vol.178, issue.4, pp.1435-1440, 1993.
DOI : 10.1084/jem.178.4.1435

M. Gheorghui, J. Augier, and P. Lagrange, Maintenance and control of the French BCG strain 1173-P2 (primary and secondary seeding lots), Bull Inst Pasteur, vol.81, pp.281-288, 1983.

S. Ehlers and E. Richter, Differential requirement for interferon-gamma to restrict the growth of or eliminate some recently identified species of nontuberculous mycobacteria in vivo, Clinical and Experimental Immunology, vol.162, issue.2, pp.229-238, 2001.
DOI : 10.1046/j.1365-2567.1999.00875.x

A. Douar, K. Poulard, D. Stockholm, and O. Danos, Intracellular Trafficking of Adeno-Associated Virus Vectors: Routing to the Late Endosomal Compartment and Proteasome Degradation, Journal of Virology, vol.75, issue.4, pp.1824-1833, 2001.
DOI : 10.1128/JVI.75.4.1824-1833.2001

R. Snyder, S. Spratt, C. Lagarde, D. Bohl, and B. Kaspar, Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice, Human Gene Therapy, vol.8, issue.16, pp.1891-1900, 1997.
DOI : 10.1089/hum.1997.8.16-1891

H. Cherwinski, J. Schumacher, K. Brown, and T. Mosmann, Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies, Journal of Experimental Medicine, vol.166, issue.5, pp.1229-1244, 1987.
DOI : 10.1084/jem.166.5.1229

M. Wysocka, M. Kubin, L. Vieira, L. Ozmen, and G. Garotta, Interleukin-12 is required for interferon-?? production and lethality in lipopolysaccharide-induced shock in mice, European Journal of Immunology, vol.180, issue.3, pp.672-676, 1995.
DOI : 10.1002/eji.1830250307

E. Belnoue, F. Costa, T. Frankenberg, A. Vigario, and T. Voza, Protective T Cell Immunity against Malaria Liver Stage after Vaccination with Live Sporozoites under Chloroquine Treatment, The Journal of Immunology, vol.172, issue.4, pp.2487-2495, 2004.
DOI : 10.4049/jimmunol.172.4.2487

C. Fieschi, S. Dupuis, C. Picard, C. Smith, and S. Holland, High Levels of Interferon Gamma in the Plasma of Children With Complete Interferon Gamma Receptor Deficiency, PEDIATRICS, vol.107, issue.4, p.48, 2001.
DOI : 10.1542/peds.107.4.e48

R. Kamijo, J. Gerecitano, D. Shapiro, S. Green, and M. Aguet, Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor, J Inflamm, vol.46, pp.23-31, 1995.

D. Canto, A. Swanson, P. , O. Guin, A. Speck et al., IFN-?? action in the media of the great elastic arteries, a novel immunoprivileged site, Journal of Clinical Investigation, vol.107, issue.2, pp.15-22, 2001.
DOI : 10.1172/JCI11540

A. Celada, The interferon gamma receptor, Lymphokine Res, vol.7, pp.61-73, 1988.

G. Valente, L. Ozmen, F. Novelli, M. Geuna, and G. Palestro, Distribution of interferon-?? receptor in human tissues, European Journal of Immunology, vol.20, issue.9, pp.2403-2412, 1992.
DOI : 10.1002/eji.1830220933

M. Farrar and R. Schreiber, The Molecular Cell Biology of Interferon-gamma and its Receptor, Annual Review of Immunology, vol.11, issue.1, pp.571-611, 1993.
DOI : 10.1146/annurev.iy.11.040193.003035

H. Broxmeyer, D. Williams, L. Lu, S. Cooper, and S. Anderson, The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma, J Immunol, vol.136, pp.4487-4495, 1986.

E. Raefsky, L. Platanias, N. Zoumbos, and N. Young, Studies of interferon as a regulator of hematopoietic cell proliferation, J Immunol, vol.135, pp.2507-2512, 1985.

C. Selleri, J. Maciejewski, T. Sato, and N. Young, Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition, Blood, vol.87, pp.4149-4157, 1996.

C. Selleri, T. Sato, S. Anderson, N. Young, and J. Maciejewski, Interferon-? and tumor necrosis factor-? suppress both early and late stages of hematopoiesis and induce programmed cell death, Journal of Cellular Physiology, vol.82, issue.3, pp.538-546, 1995.
DOI : 10.1002/jcp.1041650312

J. Maciejewski, C. Selleri, S. Anderson, and N. Young, Fas antigen expression on CD34þ human marrow cells is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates cytokine-mediated hematopoietic suppression in vitro, Blood, vol.85, pp.3183-3190, 1995.

H. Young, D. Klinman, D. Reynolds, K. Grzegorzewski, and A. Nii, Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies, Blood, vol.89, pp.583-595, 1997.

N. Zoumbos, J. Djeu, and N. Young, Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro, J Immunol, vol.133, pp.769-774, 1984.

I. Angulo, R. Rodriguez, B. Garcia, M. Medina, and J. Navarro, Involvement of nitric oxide in bone marrow-derived natural suppressor activity; its dependence on IFNg, J Immunol, vol.155, pp.15-26, 1995.

E. Toichi, G. Torres, T. Mccormick, T. Chang, and M. Mascelli, An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis, The Journal of Immunology, vol.177, issue.7, pp.4917-4926, 2006.
DOI : 10.4049/jimmunol.177.7.4917

C. Kaufmann, N. Aria, E. Toichi, T. Mccormick, and K. Cooper, A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis, Journal of Investigative Dermatology, vol.123, issue.6, pp.1037-1044, 2004.
DOI : 10.1111/j.0022-202X.2004.23448.x

P. Mannon, I. Fuss, L. Mayer, C. Elson, and W. Sandborn, Anti???Interleukin-12 Antibody for Active Crohn's Disease, New England Journal of Medicine, vol.351, issue.20, pp.2069-2079, 2004.
DOI : 10.1056/NEJMoa033402

B. Skurkovich and S. Skurkovich, Anti-interferon-gamma antibodies in the treatment of autoimmune diseases, Curr Opin Mol Ther, vol.5, pp.52-57, 2003.

G. Vogt, A. Chapgier, K. Yang, N. Chuzhanova, and J. Feinberg, Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations, Nature Genetics, vol.33, issue.7, pp.692-700, 2005.
DOI : 10.1126/science.1093941

L. Ruggeri, F. Aversa, M. Martelli, and A. Velardi, Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self, Immunological Reviews, vol.33, issue.1, pp.202-218, 2006.
DOI : 10.1182/blood-2001-12-0293

R. Renella, C. Picard, B. Neven, M. Ouaché-e-chardin, and J. Casanova, Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections, British Journal of Haematology, vol.54, issue.5, pp.510-516, 2006.
DOI : 10.1007/s002510050619